Literature DB >> 20598923

Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients.

Danitza Nebor1, Cédric Broquere, Karine Brudey, Danielle Mougenel, Vanessa Tarer, Philippe Connes, Jacques Elion, Marc Romana.   

Abstract

The aim of this study was to identify possible risk factors for albuminuria, an early marker of sickle cell anemia (SCA) glomerulopathy, in a cohort of 189 SCA adult patients followed at the Sickle Cell Center of Guadeloupe, a French Caribbean island. Biological parameters obtained at baseline, alpha-globin gene status, and beta(S) haplotypes were compared in patients stratified accordingly to graded albuminuria. Abnormal albumin excretion rate was detected in half of the studied adult patients and macroalbuminuria occurred in 21.6%. Graded albuminuria was associated with advanced age (p=0.006), systolic blood pressure (p=0.031), and worsened anemia, i.e. low hemoglobin rate (p<0.0001) and red blood cell count (p<0.0001). Alpha-thalassemia frequency was lower in microalbuminuric and macroalbuminuric patients than in normoalbuminuric patients, 12.5%, 13.75% and 26%, respectively (p=0.0057). Comparison of albuminuria-free survival curves in SCA patients without and with alpha-thalassemia showed that the median time of albuminuria onset was delayed in the later ones (p=0.021). In contrast, no association of albuminuria was detected with the Bantou beta(S) haplotype. Our results strongly suggest a protective effect of alpha-thalassemia against glomerulopathy in SCA adult patients which could be related to a decreased hemolytic rate. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20598923     DOI: 10.1016/j.bcmd.2010.06.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  14 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.

Authors:  Nathalie Lemonne; Keyne Charlot; Xavier Waltz; Samir K Ballas; Yann Lamarre; Ketty Lee; Régine Hierso; Catherine Connes; Maryse Etienne-Julan; Marc Romana; Philippe Connes
Journal:  Haematologica       Date:  2015-07-02       Impact factor: 9.941

Review 3.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.

Authors:  Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

5.  Association between hemolysis and albuminuria in adults with sickle cell anemia.

Authors:  Thomas G Day; Emma R Drasar; Tony Fulford; Claire C Sharpe; Swee Lay Thein
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Effects of Senegal haplotype (Xmn1-rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3-rs11248850 and BCL11A-rs4671393 variants on sickle cell nephropathy.

Authors:  El Hadji Malick Ndour; Khuthala Mnika; Fatou Guèye Tall; Moussa Seck; Indou Dème Ly; Victoria Nembaware; Hélène Ange Thérèse Sagna-Bassène; Rokhaya Dione; Aliou Abdoulaye Ndongo; Jean Pascal Demba Diop; Nènè Oumou Kesso Barry; Moustapha Djité; Rokhaya Ndiaye Diallo; Papa Madièye Guèye; Saliou Diop; Ibrahima Diagne; Aynina Cissé; Ambroise Wonkam; Philomène Lopez Sall
Journal:  Int J Biochem Mol Biol       Date:  2022-04-15

7.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

8.  Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia.

Authors:  Céline Renoux; Nermi Parrow; Camille Faes; Philippe Joly; Max Hardeman; John Tisdale; Mark Levine; Nathalie Garnier; Yves Bertrand; Kamila Kebaili; Daniela Cuzzubbo; Giovanna Cannas; Cyril Martin; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

9.  Sickle cell anemia: clinical diversity and beta S-globin haplotypes.

Authors:  Sandra Regina Loggetto
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 10.  Sickle Cell Anemia and Its Phenotypes.

Authors:  Thomas N Williams; Swee Lay Thein
Journal:  Annu Rev Genomics Hum Genet       Date:  2018-04-11       Impact factor: 9.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.